Five-Year Results of a Phase II Trial of Hyperfractionated Radiotherapy and Concurrent Daily Cisplatin Chemotherapy for Stage III Non-Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Five-Year Results of a Phase II Trial of Hyperfractionated Radiotherapy and Concurrent Daily Cisplatin Chemotherapy for Stage III Non-Small-Cell Lung Cancer

Published:2005-06 Issue:3 Volume:28 Page:217-222
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Keene Kimberly S.,Harman Eloise M.,Knauf Daniel G.,McCarley Dean,Zlotecki Robert A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference21 articles.

1. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses 60.0 Gy to 79.2 Gy; possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma; report of Radiation Therapy Oncology Group 83–11.;Cox;J Clin Oncol,1990

2. Radiotherapy combined with low-dose cis-diammine dichloroplatinum (II) (CDDP) in inoperable nonmetastatic non-small cell lung cancer (NSCLS): a randomized three arm phase II study of the EORTC Lung Cancer and Radiotherapy Cooperative Groups.;Schaake-Koning;Int J Radiat Oncol Biol Phys,1990

3. Five-year survival after hyperfractionated radiation therapy for non-small-cell carcinoma of the lung (NSCLC): 1. C Results of the RTOG protocol 81–08.;Cox;Am J Clin Oncol,1991

4. Radiation Therapy Oncology Group (RTOG) 88–08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer.;Sause;J Natl Cancer Inst,1995

5. Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small cell lung cancer: results of the EORTC 08912 phase I/II study. European Organization for Research and Treatment of Cancer.;Uitterhoeve;Eur J Cancer,2000

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncology's trial and error: Analysis of the FDA withdrawn accelerated approvals;Life Sciences;2024-06

2. Consolidation Systemic Therapy in Locally Advanced, Inoperable Nonsmall Cell Lung Cancer—How to Identify Patients Which Can Benefit from It?;Current Oncology;2022-10-31

3. Combined Radiation Therapy and Chemotherapy as an Exclusive Treatment Option in Locally Advanced Inoperable Non-small Cell Lung Cancer;Medical Radiology;2021

4. Long-term follow-up of phase II trial of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small cell lung cancer;Acta Oncologica;2011-11-16

5. Definitive Altered Fractionation Radiotherapy and Concomitant Weekly Cisplatin for Locally Advanced Head and Neck Cancer;American Journal of Clinical Oncology;2009-10